The Journal of Nutrition Vol. 127 No. 11 November 1997, pp. 2212-2216
Copyright ©1997 by the American Society for Nutritional Sciences

Biotin Biotransformation to Bisnorbiotin Is Accelerated by Several Peroxisome Proliferators and Steroid Hormones in Rats

Kuen-Shian Wang, Nell I. Mock, and Donald M. Mock

Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, University of Arkansas for Medical Sciences and Arkansas Children's Hospital Research Institute, Little Rock, AR 72202-3591

Bisnorbiotin and biotin sulfoxide are the major catabolites of biotin for humans, swine, and rats. Increased urinary excretion of bisnorbiotin, biotin sulfoxide, or both have been observed during pregnancy and in patients treated with certain anticonvulsants. We sought more insight into the sites and mechanisms of biotin catabolism by exposing rats in vivo to compounds known to induce classes of enzymes that were candidates to catalyze the biotransformations. Rats were treated with the anticonvulsants phenytoin, phenobarbital, and carbamazepine, the steroid hormones dexamethasone and dehydroepiandrosterone, and the peroxisome proliferators clofibrate and di(2-ethylhexyl)phthalate. [¹⁴C]Biotin was injected intraperitoneally at physiologic doses in treated rats and control rats; HPLC and radiometric flow detection were used to specifically identify and quantify [¹⁴C]biotin and its metabolites in urine. Treatment effects were assessed by the change in the urinary excretion of [¹⁴C]bisnorbiotin and [¹⁴C]biotin sulfoxide in response to administration of [¹⁴C]biotin. No significant changes resulted from treatment with any of the anticonvulsants. With the steroid hormones and the peroxisome proliferators, [¹⁴C]bisnorbiotin excretion increased significantly. These results indicate that biotin is converted into bisnorbiotin in the liver and that this conversion likely occurs in peroxisomes or mitochondria or both via -oxidative cleavage, and, in contrast to responses in humans, the enzymes responsible for the formation of biotin sulfoxide in rats are not induced by the anticonvulsants examined here.

This article has been cited by other articles:

				N. Kothapalli, G. Sarath, and J. Zempleni Biotinylation of K12 in Histone H4 Decreases in Response to DNA Double-Strand Breaks in Human JAr Choriocarcinoma Cells J. Nutr., October 1, 2005; 135(10): 2337 - 2342. [Abstract] [Full Text] [PDF]

				S. C. Rathman, J. F. Gregory III, and R. J. McMahon Pharmacological Biotin Supplementation Maintains Biotin Status and Function in Rats Administered Dietary Carbamazepine J. Nutr., September 1, 2003; 133(9): 2857 - 2862. [Abstract] [Full Text] [PDF]

				S. C. Rathman, S. Eisenschenk, and R. J. McMahon The Abundance and Function of Biotin-Dependent Enzymes Are Reduced in Rats Chronically Administered Carbamazepine J. Nutr., November 1, 2002; 132(11): 3405 - 3410. [Abstract] [Full Text] [PDF]

				S. C. Rathman, B. Lewis, and R. J. McMahon Acute glucocorticoid treatment increases urinary biotin excretion and serum biotin Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E643 - E649. [Abstract] [Full Text] [PDF]

				H. M Said Biotin: the forgotten vitamin Am. J. Clinical Nutrition, February 1, 2002; 75(2): 179 - 180. [Full Text] [PDF]

				J. Zempleni and D. M. Mock Marginal Biotin Deficiency Is Teratogenic Experimental Biology and Medicine, January 1, 2000; 223(1): 14 - 21. [Abstract] [Full Text]

				J. Zempleni and D. M. Mock Advanced Analysis of Biotin Metabolites in Body Fluids Allows a More Accurate Measurement of Biotin Bioavailability and Metabolism in Humans J. Nutr., February 1, 1999; 129(2): 494 - 494. [Abstract] [Full Text] [PDF]